Profarma Expects $170 Million From Share Float

Profarma Expects $170 Million From Share Float

Equity

Brazilian pharmaceuticals distributor Profarma expects to raise up to $170 million from its sale of 15.5 million common shares through an initial public offering (IPO) on Bovespa. The share offering will comprise 12 million shares sold via a primary offering and 3.5 million via a secondary sale. Credit Suisse will coordinate. The shares will be priced October 24 once bookbuilding is completed. The Rio de Janeiro-based company is among the top three medicines distribution companies in the country

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial